Bolt Biotherapeutics Inc. logo

Bolt Biotherapeutics Inc.

BOLT | NASDAQ
Chart Builder DCF Calculator
$3.50
-$0.09 (-2.51%)
Sep 22, 2026, 11:51 AM ET · Market open
Fiscal Year
Period Ending
FY 2025
Dec 30, 2025
FY 2024
Dec 30, 2024
FY 2023
Dec 30, 2023
FY 2022
Dec 30, 2022
FY 2021
Dec 30, 2021
FY 2020
Dec 30, 2020
Net Income
-33.38M -63.12M -69.2M -88.1M -98.59M -60.73M
Depreciation & Amortization
1.29M 1.78M 1.85M 1.67M 1.19M 611K
Stock-Based Compensation
2.78M 7.41M 9.22M 9.58M 8.5M 1.42M
Other Working Capital
-12.12M -8.44M -6.45M -5.83M 13.83M -5.17M
Other Non-Cash Items
1.57M 1.08M -1.54M 3.41M 8.56M 13.64M
Deferred Income Tax
n/a n/a n/a n/a 2.76M 34K
Change in Working Capital
-12.12M -8.44M -9.86M -3.06M 20.51M -2.28M
Operating Cash Flow
-39.85M -61.29M -69.53M -76.5M -57.07M -47.31M
Capital Expenditures
-72K -41K -206K -1.95M -2.34M -3.26M
Cash Acquisitions
963K 148K n/a -59.82M 229.86M 17.33M
Purchase of Investments
-29.02M -88.86M -164.99M -180.7M -313.38M -33.23M
Sales Maturities Of Investments
72.43M 146.32M 236.23M 240.52M 83.51M 15.9M
Other Investing Acitivies
n/a n/a n/a 59.82M -229.86M -17.33M
Investing Cash Flow
44.3M 57.58M 71.04M 57.86M -232.2M -20.59M
Debt Repayment
n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a n/a n/a n/a -1.97M
Financial Cash Flow
19K 108K 253K 503K 311.11M 39.6M
Net Cash Flow
4.47M -3.61M 1.77M -18.14M 21.84M -28.3M
Free Cash Flow
-39.92M -61.33M -69.73M -78.46M -59.4M -50.57M
Adj. Free Cash Flow
-42.7M -68.74M -78.95M -88.03M -67.9M -51.99M
Maintenance CapEx
-46.51K -41K n/a n/a n/a -2.21M
Growth CapEx
-25.49K n/a -206K -1.95M -2.34M -1.05M
Owner Earnings
-39.9M -61.33M -69.53M -76.5M -57.07M -49.52M

© 2026 bestshares.com. All rights reserved.